| Product Code: ETC12773112 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan NSCLC Therapeutics Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan NSCLC Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan NSCLC Therapeutics Market - Industry Life Cycle |
3.4 Afghanistan NSCLC Therapeutics Market - Porter's Five Forces |
3.5 Afghanistan NSCLC Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Afghanistan NSCLC Therapeutics Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Afghanistan NSCLC Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Afghanistan NSCLC Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Afghanistan NSCLC Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer (NSCLC) in Afghanistan |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of NSCLC |
4.2.3 Rising healthcare expenditure in Afghanistan to improve cancer care facilities |
4.3 Market Restraints |
4.3.1 Limited access to advanced NSCLC therapeutics in remote areas of Afghanistan |
4.3.2 High cost of NSCLC treatments leading to affordability issues for patients |
5 Afghanistan NSCLC Therapeutics Market Trends |
6 Afghanistan NSCLC Therapeutics Market, By Types |
6.1 Afghanistan NSCLC Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021 - 2031F |
6.1.5 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2 Afghanistan NSCLC Therapeutics Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Pembrolizumab, 2021 - 2031F |
6.2.3 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Erlotinib, 2021 - 2031F |
6.2.4 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Cisplatin, 2021 - 2031F |
6.2.5 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Stereotactic Body Radiation, 2021 - 2031F |
6.3 Afghanistan NSCLC Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Afghanistan NSCLC Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.3 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.4 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Advanced Cancer Treatment, 2021 - 2031F |
6.4.5 Afghanistan NSCLC Therapeutics Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
7 Afghanistan NSCLC Therapeutics Market Import-Export Trade Statistics |
7.1 Afghanistan NSCLC Therapeutics Market Export to Major Countries |
7.2 Afghanistan NSCLC Therapeutics Market Imports from Major Countries |
8 Afghanistan NSCLC Therapeutics Market Key Performance Indicators |
8.1 Number of NSCLC patients diagnosed at an early stage |
8.2 Percentage of NSCLC patients receiving timely and appropriate treatment |
8.3 Adoption rate of new NSCLC therapeutics in the Afghan healthcare system |
9 Afghanistan NSCLC Therapeutics Market - Opportunity Assessment |
9.1 Afghanistan NSCLC Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Afghanistan NSCLC Therapeutics Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Afghanistan NSCLC Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Afghanistan NSCLC Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Afghanistan NSCLC Therapeutics Market - Competitive Landscape |
10.1 Afghanistan NSCLC Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan NSCLC Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here